Retrievability of uncoated versus paclitaxel-coated Günther-Tulip IVC filters in an animal model

Journal of Vascular and Interventional Radiology

Volumn 15, Issue 7, 2004, Pages 719-726

  De Gregorio, Miguel Angel ^a,c   Gimeno, María José ^a   Lostalé, Fernando ^a   Iñigo, Pablo ^a   Artigas, María Consuelo ^a   Viloria, Américo ^a   Alfonso, Eduardo Ramón ^a   D'Agostino, Horacio ^b  

^a UNIVERSITY OF ZARAGOZA   (Spain)

^b Louisiana State University Health Sciences Center at Shreveport   (United States)

^c HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

IOVERSOL; PACLITAXEL;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL WALL; CAVOGRAPHY; DRUG COATING; FILTER DESIGN; INFERIOR CAVA VEIN; LAPAROTOMY; NONHUMAN; PILOT STUDY; PRIORITY JOURNAL; RETRIEVABLE FILTER; SWINE; VASCULAR ENDOTHELIUM; VASCULAR FIBROSIS; VENA CAVA FILTER;

EID: 3042857310     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.RVI.0000133512.20764.D8     Document Type: Article

References (26)

1. Decousus H, Leizorovicz A, Parent F, et al. A clinical trial of vena cava filters in the prevention of pulmonary embolism in patients with proximal deep vein thrombosis. N Engl J Med 1998; 409-415.
2. Kauczor HU. Pulmonary embolism from diagnosis to treatment. Cardiovasc Intervent Radiol 2000; 23 (suppl 1):s53-s55.
3. De Gregorio MA, Gimeno MJ, Tobio R, et al. Animal experience in the Gunther Tulip retrievable inferior vena cava filter. Cardiovasc Intervent Radiol 2001; 24:413-417.
4. Neuerburg J, Gunther R, Rassmussen E, et al. New retrievable percutaneous vena cava filter: experimental in vitro and vivo evolution. Cardiovasc Intervent Radiol 1993; 16:224-229.
5. Millward SF, Oliva VL, Bell S, et al. Gunther Tulip retrievable vena cava filter: results from the registry of the Canadian Interventional Radiology Association. J Vasc Interv Radiol 2001; 12:1053-1058.
6. Given M, Lyon S, Foster A, Mc Grath F, Lee M. Retrievable Gunther-Tulip filter. Experience in 41 patients. Radiology 2002; 225(suppl):642.
7. Morice MC, Serruys PW, Sousa JE, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002; 346:1773-1780.
8. Hong M, Kornowski R, Bramwell O, Ragheb A, Leon M. Paclitaxel-coated Gianturco-Roubin II (GR II) stents reduce neointimal hyperplasia in a porcine coronary in stent restenosis model. Coron Artery Dis 2001; 12:513-515.
9. Kinney T. Update on inferior vena cava filters. J Vasc Interv Radiol 2003; 14:425-440.
10. Epstein Dh, Darcy Md, Hunter DW, et al. Experience with Amplatz retrievable vena cava filter. Radiology 1989; 172:105-110.
11. Nakagawa N, Cragg A, Smith TP, Castañeda F, Barnhart W, DeJong SC. A retrievable nitinol vena cava filter: experience and initial clinical results. J Vasc Interv Radiol 1994; 5:507-512.
12. Vorwerk D, Gunther RW, Schurmann K, Schmitz-Rode T. New device for wire and catheter capturing: in vivo experiments and first clinical experience. Cardiovasc Intervent Radiol 1995; 18:312-314.
13. Asch M. Initial experience in humans with a new retrievable inferior vena cava filter. Radiology 2002; 225:835-844.
14. Millward SF. Temporary and retrievable inferior vena cava filters: current status. J Vasc Interv Radiol 1998; 9:381-387.
15. Neuerburg JM, Gunther RW, Vorwerk D, et al. Results of a multicenter study of the retrievable Tulip vena cava filter: early clinical experience. Cardiovasc Intervent Radiol 1997; 20:10-16.
16. Millward SF, Bhargava A, Aquino J, et al. Günther Tulip filter: preliminary clinical experience with retrieval. J Vasc Interv Radiol 2000; 11:75-82.
17. Millward S. Gunther Tulip retrievable filter: why, when and how? Can Assoc Radiol J 2001; 52:188-92.
18. Lorch H, Welger D, Wagner V, et al. Current practice of temporary vena cava filter insertion: a multicenter registry. J Vasc Interv Radiol 2000; 11:83-88.
19. Abbott G. Prophylactic use of temporary IVC filters for prevention of pulmonary thromboembolization in a district general hospital. J Vasc Interv Radiol 1999; 10(suppl):288.
20. Border WA, Noble NA. Transforming growth factor beta tissue fibrosis. N Engl J Med 1994; 331:1286-1292.
21. Border WA, Noble NA. Interactions of transforming growth factor-beta and angiotensin II in renal fibrosis. Hypertension 1998; 31:181-188.
22. Leivo T, Arjomaa P, Oivula J, et al. Differential modulation of transforming growth factor-beta by betamethasone-17-valerate and isotretinoin: corticosteroid decreases and isotretinoin increases the level of transforming growth factor-beta in suction blister fluid. Skin Pharmacol Appl Skin Physiol 2000; 13:150-156.
23. Zhu J, Wu J, Frizell E, et al. Rapamycin inhibits hepatic stellate cell proliferation in vitro and limits fibrogenesis in an in vivo model of liver fibrosis. Gastroenterology 1999; 117:1198-1204.
24. Fattori R, Piva T. Drug eluting stents in vascular intervention. Lancet 2003; 361:247-249.
25. Tay K, Martin M, Fry P, Webb J, Machan L. Repeated Günther Tulip inferior vena cava filter repositioning to prolong implantation time. J Vasc Interv Radiol 2002; 13:509-512.
26. De Gregorio MA, Gamboa P, Gimeno MJ, et al. The Guenther-Tulip retrievable filter: prolonged temporary filtration by percutaneous repositioning within the inferior vena cava. J Vasc Interv Radiol 2003; 14:1259-1265.